Abstract
Low doses of recombinant interferon alpha 2b were used to treat two patients with Kaposi's sarcoma not associated with AIDS. Clinical benefit was obtained after a few months in both cases. In one case dynamic telethermography demonstrated regression of the disease after 9 months of treatment. No serious side-effects were observed during interferon administration. We conclude that recombinant interferon alpha 2b could be considered a treatment of choice for Kaposi's sarcoma not associated with AIDS.
Original language | English |
---|---|
Pages (from-to) | 209-210 |
Number of pages | 2 |
Journal | Journal of Dermatological Treatment |
Volume | 1 |
Issue number | 4 |
DOIs | |
Publication status | Published - 1990 |
ASJC Scopus subject areas
- Dermatology